Omrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare Conference

  
    
  
  
    
      Omrix Biopharmaceuticals, Inc. (“Omrix”) 
      (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that 
      develops and markets biosurgical and immunotherapy products, announced 
      today that Nissim Mashiach, President & Chief Operating Officer, is 
      scheduled to give a company presentation at the Credit Suisse Annual 
      Global Healthcare Conference on Friday, November 14, 2008 at 9:00 a.m. 
      Mountain Standard Time; 11:00 am Eastern Standard Time at the Arizona 
      Biltmore Resort & Spa in Phoenix, Arizona.
    
    
      A live webcast of the presentation will be available on the Company's 
      corporate web site at www.omrix.com. 
      Participants are urged to log on to the web site 15 minutes prior to the 
      scheduled start time to download and install any necessary audio 
      software. A replay of the webcast will be available within 24 hours 
      after the live presentation time and will be available for 30 days.
    
    
      About Omrix Biopharmaceuticals, Inc.
    
    
      Omrix is a fully integrated biopharmaceutical company that develops, 
      manufactures and markets protein-based biosurgery and passive 
      immunotherapy products. Omrix' biosurgery product line includes products 
      and product candidates that are used for the control of bleeding, or 
      hemostasis, and other surgical applications. The Company's passive 
      immunotherapy product line includes antibody-rich products and product 
      candidates for the treatment of immune deficiencies, infectious diseases 
      and potential biodefense applications. For more information, please 
      visit www.omrix.com.
    
    
      Safe Harbor Statement
    
    
      This news release contains forward-looking statements. Forward-looking 
      statements provide the Company's current expectations or forecasts of 
      future events. Forward-looking statements include statements about the 
      Company's expectations, beliefs, plans, objectives, intentions, 
      assumptions and other statements that are not historical facts. 
      Forward-looking statements are subject to known and unknown risks and 
      uncertainties and are based on potentially inaccurate assumptions that 
      could cause actual results to differ materially from those expected or 
      implied by the forward-looking statements. The Company's actual results 
      could differ materially from those anticipated in forward-looking 
      statements for many reasons, including the factors described in the 
      Company's filings with the Securities and Exchange Commission (SEC), 
      including sections entitled "Risk Factors" and "Management's Discussion 
      and Analysis of Financial Condition and Results of Operations" in the 
      Company's Form 10-K as filed with the SEC on March 17, 2008, and the 
      Company's most recent quarterly reports on Form 10-Q and its current 
      reports on Form 8-K. Unless required by law, the Company undertakes no 
      obligation to publicly update or revise any forward-looking statement to 
      reflect circumstances or events after the date of this news release.